Trump White House Budget Proposal Likely to Do Little to Make Medicines More Affordable; Public Citizen Experts Available for Comment
MEDIA ADVISORY
Feb. 12, 2018
Trump White House Budget Proposal Likely to Do Little to Make Medicines More Affordable; Public Citizen Experts Available for Comment
WHAT: Public Citizen’s experts are available to comment on the expected release of the White House’s budget proposal, which also is expected to contain Trump administration plans to address prescription medicines affordability.
At a time when the U.S. is facing a nationwide crisis of access to affordable medicines, the administration is failing the litmus test on medicine affordability. The problem with the Trump budget proposal is that it refuses to take measures to curtail Big Pharma’s pricing abuses and avoids taking on the monopolies that reinforce the industry’s marketing power.
Public Citizen believes the Trump administration budget proposal would better serve American consumers by:
1. Leveraging government negotiating power;
2. Ending annual prescription price spikes; and
3. Curbing monopoly abuse.
WHO: Peter Maybarduk, director, Public Citizen’s Access to Medicines program
Steve Knievel, advocate, Public Citizen’s Access to Medicines program